Sucampo Investor Seeks Docs For Proposed Mallinckrodt Deal
A shareholder hit Sucampo Pharmaceuticals Inc. with a books and records request suit Monday in Delaware's Chancery Court over Mallinckrodt PLC's proposed $1.2 billion buyout, alleging Mallinckrodt may have acquired an...To view the full article, register now.
Already a subscriber? Click here to view full article